Lions & Lambs in the Device & DX Industries
Do big companies differ from small companies only in the size of their resource pool? The different, if not imcompatible perspectives of big and small companies was a recurring theme of the formal sessions and informal discussions at Phoenix '96, a conference for CEOs of medical device and diagnostics companies.
You may also be interested in...
Following the announcement in the US that ranitidine drugs must be withdrawn from the market, the European Medicines Agency told the Pink Sheet it would decide on the fate of these medicines in the EU after wrapping up its own inquiry.
In addition to our daily in-depth coverage of key events relating to the COVID-19 pandemic, we’re bringing you a periodic round-up of other developments. This edition covers Europe and other countries.
EU drug industry federation, EFPIA, is concerned that an increase in protectionist trade measures by some countries could result in tit-for-tat policies that could hamper the global response to contain COVID-19.